About the program
Submit a Proposal
Contact Us

About the program

In 2012, Bayer launched the Global Ophthalmology  Awards Program (GOAP) with the aim of advancing the scientific understanding  and clinical management of retinal ophthalmic disorders. Through grants supporting research and training in  ophthalmology, the program seeks to provide opportunities for treatment  improvement.

  Current Award Recipients

Research Award

Dr Magda Meester-Smoor
Research institution: Erasmus MC, Rotterdam, The Netherlands
Project title: Why is good cholesterol bad for AMD?

Dr Ranju Kharel Sitaula
Research institution: Tribhuvan University, Kathmandu, Nepal
Project title: Biomarkers, sequencing and phenotyping of seasonal hyperacute panuveitis (shapu)

Associate Professor Matthew Patrick Simunovic
Research institution: Save Sight Institute, University of Sydney, Australia
Project title: Cone light adaptation as a biomarker for Müller cell dysfunction

Dr Timothy Yap
Research institution: Imperial College London, London, UK
Project title: Assessment of ocular islet cell transplantation as a treatment of early diabetic retinopathy using retinal imaging biomarkers

Dr Rwituja Thomas
Research institution: Narayana Nethralaya Eye Institute, Bangalore, India
Project title: Predicting retinopathy of prematurity (ROP) in infants from biomarkers in their tears

Dr Mali Okada
Research institution: University of Melbourne, Melbourne, Australia
Project title: Functional testing of diabetic retinal micro-vascular networks to determine who is at risk of disease progression

Dr Eri Takahashi
Research institution:Kumamoto University, Kumamoto, Japan
Project title: Exosomal miRNA as biomarkers

Dr Tomohiro Niizawa
Research institution: Wilmer Eye Institute, Johns Hopkins University, USA
Project title: The role of mast cells and their release of tryptase during degranulation in geographic atrophy

Dr Enrico Borrelli
Research institution: San Raffaele Scientific Institute, Milan, Italy
Project title: Surviving diabetes without complications: A patient-driven approach

Dr Melissa Kaye Jones
Research institution: University of California San Diego, San Diego, USA
Project title: Secreted miRNAs serve as biomarkers of AMD like progression in human stem cell-derived RPE

Dr Elodie Bousquet
Research institution: INSERM, Paris, France
Project title: Comparative ocular steroidome in normal subjects and patients with retinal diseases

Dr Xitiz Chamling
Research institution: Wilmer Eye Institute, Johns Hopkins University, Baltimore, USA
Project title: Novel retinal ganglion cell neuroprotective pathways as an approach for treatment of glaucoma
©2019 Bayer. All rights reserved.
General Conditions of Use | Privacy Statement | Imprint | Program Terms and Conditions

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc. Tel.: 0118 2063500, Fax.: 0118 2063703
Email: pvuk@bayer.com
If you want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com
For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy